InvestorsHub Logo
Followers 0
Posts 2
Boards Moderated 0
Alias Born 07/09/2019

Re: None

Tuesday, 07/09/2019 10:13:31 AM

Tuesday, July 09, 2019 10:13:31 AM

Post# of 235
Clinical Laserthermia Systems could announce yet another step forward in the development of its immune stimulating laser ablation method, imILT. The company will collaborate with a private Portuguese cancer clinic, Hospital da Luz, concerning the treatment of solid cancer tumours with imILT in patients that have requested the treatment.


The deal concerns treatment with the company’s flagship project Immune-stimulating interstitial thermotherapy (imILT), a laser-controlled thermal therapy aimed at the outer surface of the tumour, where the tumour grows. By channelling heat into the tumour and reaching a low, non-coagulating temperature in the outer edges of the tumour, antigens are released creating an immune response that also attacks metastases in the body. CLS’s own system to monitor the treatment, TRANBERG Thermo Therapy System, will be used.


https://www.biostock.se/cls-collaborates-with-portuguese-cancer-clinic/

Probably the best laser in the world!

$clsb $mric